{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:12:43Z","timestamp":1789827163392,"version":"4.0.1"},"reference-count":168,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["634413"],"award-info":[{"award-number":["634413"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 1292\/08"],"award-info":[{"award-number":["CRC 1292\/08"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG CRC 1066\/B3"],"award-info":[{"award-number":["DFG CRC 1066\/B3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1053\/j.gastro.2019.04.050","type":"journal-article","created":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T11:00:09Z","timestamp":1557572409000},"page":"365-381.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"title":["Clinical Guide and Update on Porphyrias"],"prefix":"10.1053","volume":"157","author":[{"given":"Ulrich","family":"St\u00f6lzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred O.","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2716-8239","authenticated-orcid":false,"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2019.04.050_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/694297","article-title":"Eggshell biliverdin and protoporphyrin pigments in a songbird: are they derived from erythrocytes, blood plasma, or the shell gland?","volume":"90","author":"Hargitai","year":"2017","journal-title":"Physiol Biochem Zool"},{"key":"10.1053\/j.gastro.2019.04.050_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/j.2040-4603.2013.tb00488.x","article-title":"Porphyrin and heme metabolism and the porphyrias","volume":"3","author":"Bonkovsky","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1053\/j.gastro.2019.04.050_bib3","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24767","article-title":"Erythropoietin signaling regulates heme biosynthesis","volume":"6","author":"Chung","year":"2017","journal-title":"Elife"},{"key":"10.1053\/j.gastro.2019.04.050_bib4","first-page":"573","article-title":"Hepatic porphyrias: pathobiochemical, diagnostic, and therapeutic implications","volume":"7","author":"Doss","year":"1982","journal-title":"Prog Liver Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","volume":"375","author":"Puy","year":"2010","journal-title":"Porphyrias. Lancet"},{"key":"10.1053\/j.gastro.2019.04.050_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00498254.2015.1085111","article-title":"Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III","volume":"46","author":"Bednarczyk","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1053\/j.gastro.2019.04.050_bib8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/ejhg.2015.181","article-title":"Genetic and biochemical study of dual hereditary jaundice: Dubin-Johnson and Gilbert\u2019s syndromes. Haplotyping and founder effect of deletion in ABCC2","volume":"24","author":"Slachtova","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib9","article-title":"Human biomonitoring of lead exposure","volume":"17","author":"Klotz","year":"2017","journal-title":"Met Ions Life Sci"},{"key":"10.1053\/j.gastro.2019.04.050_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.116.234914","article-title":"Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide inhibition","volume":"358","author":"Lai","year":"2016","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1053\/j.gastro.2019.04.050_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12878-017-0082-z","article-title":"Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan preschool children: a community-based survey","volume":"17","author":"Teshome","year":"2017","journal-title":"BMC Hematol"},{"key":"10.1053\/j.gastro.2019.04.050_bib12","doi-asserted-by":"crossref","first-page":"10776","DOI":"10.1038\/ncomms10776","article-title":"Non-invasive detection of iron deficiency by fluorescence measurement of erythrocyte zinc protoporphyrin in the lip","volume":"7","author":"Hennig","year":"2016","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2019.04.050_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/alcalc\/35.2.109","article-title":"Alcohol and porphyrin metabolism","volume":"35","author":"Doss","year":"2000","journal-title":"Alcohol Alcohol"},{"key":"10.1053\/j.gastro.2019.04.050_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng809","article-title":"The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH","volume":"30","author":"Gouya","year":"2002","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1365-2133.2001.04147.x","article-title":"Homozygous variegate porphyria: a compound heterozygote with novel mutations in the protoporphyrinogen oxidase gene","volume":"144","author":"Palmer","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib18","first-page":"861","article-title":"Residual activity of human porphobilinogen deaminase with R167Q or R167W mutations: an explanation for survival of homozygous and compound heterozygous acute intermittent porphyrics","volume":"48","author":"Edixhoven-Bosdijk","year":"2002","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"Suppl","key":"10.1053\/j.gastro.2019.04.050_bib19","first-page":"OL1855","article-title":"An odd case of heteroallelic acute intermittent porphyria in the Argentinean population","volume":"59","author":"Pi\u00f1eiro Pauwels","year":"2013","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1053\/j.gastro.2019.04.050_bib20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddy030","article-title":"From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria","volume":"27","author":"Lenglet","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2141.2005.05852.x","article-title":"Dual gene defects involving delta-aminolaevulinate dehydratase and coproporphyrinogen oxidase in a porphyria patient","volume":"132","author":"Akagi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.gastro.2019.04.050_bib22","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1111\/j.1440-0960.2011.00875.x","article-title":"Co-existence of hereditary coproporphyria and porphyria cutanea tarda: the importance of genetic testing","volume":"54","author":"Rudd","year":"2013","journal-title":"Australas J Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2119\/molmed.2015.00099","article-title":"Liver transplantation for acute intermittent porphyria: biochemical and pathologic studies of the explanted liver","volume":"21","author":"Yasuda","year":"2015","journal-title":"Mol Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib24","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116348","article-title":"Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria","volume":"91","author":"Meissner","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1053\/j.gastro.2019.04.050_bib25","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130045","article-title":"Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria","volume":"33","author":"Bustad","year":"2013","journal-title":"Biosci Rep"},{"key":"10.1053\/j.gastro.2019.04.050_bib26","doi-asserted-by":"crossref","first-page":"34717","DOI":"10.1074\/jbc.M204699200","article-title":"Drugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR)","volume":"277","author":"Fraser","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.gastro.2019.04.050_bib27","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1073\/pnas.0401845101","article-title":"Identification of the xenosensors regulating human 5-aminolevulinate synthase","volume":"101","author":"Podvinec","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.gastro.2019.04.050_bib28","doi-asserted-by":"crossref","first-page":"39392","DOI":"10.1074\/jbc.M306148200","article-title":"Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene","volume":"278","author":"Fraser","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.gastro.2019.04.050_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-4165(02)00482-8","article-title":"Phenobarbital induction of drug\/steroid-metabolizing enzymes and nuclear receptor CAR","volume":"1619","author":"Kakizaki","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.gastro.2019.04.050_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cell.2005.06.040","article-title":"Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha","volume":"122","author":"Handschin","year":"2005","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2019.04.050_bib31","doi-asserted-by":"crossref","first-page":"22510","DOI":"10.1073\/pnas.0912533106","article-title":"PGC-1\u03b1 negatively regulates hepatic FGF21 expression by modulating the heme\/Rev-Erb\u03b1 axis","volume":"106","author":"Estall","year":"2009","journal-title":"PNAS"},{"key":"10.1053\/j.gastro.2019.04.050_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jb\/mvm159","article-title":"Haeme-regulated degradation of delta-aminolevulinate synthase 1 in rat liver mitochondria","volume":"142","author":"Yoshino","year":"2007","journal-title":"J\u00a0Biochem"},{"key":"10.1053\/j.gastro.2019.04.050_bib33","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/j.1476-5381.2010.00990.x","article-title":"Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects","volume":"161","author":"Doberer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1053\/j.gastro.2019.04.050_bib34","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/BF01481493","article-title":"New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation","volume":"57","author":"Doss","year":"1979","journal-title":"Klin Wochenschr"},{"key":"10.1053\/j.gastro.2019.04.050_bib35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/B:BOLI.0000037341.21975.9d","article-title":"The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany","volume":"27","author":"Doss","year":"2004","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00378728","article-title":"Lead poisoning in inherited delta-aminolevulinic acid dehydratase deficiency","volume":"54","author":"Doss","year":"1984","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1053\/j.gastro.2019.04.050_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/511444","article-title":"ALAD porphyria is a conformational disease","volume":"80","author":"Jaffe","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib38","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.2016080918","article-title":"A\u00a0variant of peptide transporter 2 predicts the severity of porphyria-associated kidney disease","volume":"28","author":"Tchernitchko","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.gastro.2019.04.050_bib39","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1471-4159.2007.04905.x","article-title":"Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity","volume":"103","author":"Hu","year":"2007","journal-title":"J\u00a0Neurochem"},{"key":"10.1053\/j.gastro.2019.04.050_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10545-010-9237-9","article-title":"Harderoporphyria due to homozygosity for coproporphyrinogen oxidase missense mutation H327R","volume":"34","author":"Hasanoglu","year":"2011","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib41","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1093\/hmg\/ddi342","article-title":"Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria","volume":"14","author":"Schmitt","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib42","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI111039","article-title":"Harderoporphyria: a variant hereditary coproporphyria","volume":"72","author":"Nordmann","year":"1983","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2019.04.050_bib43","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.29313","article-title":"Acute hepatic porphyrias: recommendations for evaluation and long term management","volume":"66","author":"Balwani","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.04.050_bib44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10545-018-0178-z","article-title":"Medical and financial burden of acute intermittent porphyria","volume":"41","author":"Neeleman","year":"2018","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1373\/clinchem.2003.027623","article-title":"Diagnosing acute porphyrias","volume":"50","author":"Sandberg","year":"2004","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2019.04.050_bib46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjmed.2014.10.026","article-title":"Role of delta-aminolevulinic acid in the symptoms of acute porphyria","volume":"128","author":"Bissell","year":"2015","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jclinpath-2012-201367","article-title":"Urinary excretion of porphyrins, porphobilinogen and \u03b4-aminolaevulinic acid following an attack of acute intermittent porphyria","volume":"67","author":"Marsden","year":"2014","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1053\/j.gastro.2019.04.050_bib48","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/clinchem\/48.11.1891","article-title":"Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families","volume":"48","author":"Kauppinen","year":"2002","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2019.04.050_bib49","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1440-1746.1996.tb00035.x","article-title":"Review: molecular pathogenesis of hepatic acute porphyrias","volume":"11","author":"Grandchamp","year":"1996","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib50","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/humu.23067","article-title":"Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease","volume":"37","author":"Chen","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1053\/j.gastro.2019.04.050_bib51","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.68.11.2725","article-title":"Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin","volume":"68","author":"Bonkowsky","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.gastro.2019.04.050_bib52","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1001\/archinte.1993.00410170078008","article-title":"Early administration of heme arginate for acute porphyric attacks","volume":"153","author":"Mustajoki","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib53","first-page":"5","article-title":"Acute hepatic porphyrias. Detection, prophylaxis and treatment","volume":"28","author":"Kostrzewska","year":"1996","journal-title":"Mater Med Pol"},{"key":"10.1053\/j.gastro.2019.04.050_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005792-197905000-00005","article-title":"Hematin therapy for acute porphyria","volume":"58","author":"Lamon","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2019.04.050_bib55","first-page":"161","article-title":"Treatment with haematin in acute hepatic porphyria","volume":"50","author":"McColl","year":"1981","journal-title":"Q\u00a0J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2008-1040702","article-title":"Hematin therapy for the porphyric attack","volume":"2","author":"Pierach","year":"1982","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.md.0000152454.56435.f3","article-title":"An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity","volume":"84","author":"Hift","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2019.04.050_bib58","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib59","doi-asserted-by":"crossref","first-page":"801.e19","DOI":"10.1016\/j.amjmed.2006.05.026","article-title":"Open-label study of hemin for acute porphyria: clinical practice implications","volume":"119","author":"Anderson","year":"2006","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib60","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(89)92688-3","article-title":"Controlled trial of haem arginate in acute hepatic porphyria","volume":"1","author":"Herrick","year":"1989","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2019.04.050_bib61","first-page":"505","article-title":"\u201cGlucose effect\u201d and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias","volume":"23","author":"Doss","year":"1985","journal-title":"J\u00a0Clin Chem Clin Biochem"},{"key":"10.1053\/j.gastro.2019.04.050_bib62","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib63","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/erm.2016.18","article-title":"Emerging therapies for acute intermittent porphyria","volume":"18","author":"Fontanellas","year":"2016","journal-title":"Expert Rev Mol Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib64","first-page":"147","article-title":"Safe and probably safe drugs in acute hepatic porphyria","volume":"55","author":"St\u00f6lzel","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1053\/j.gastro.2019.04.050_bib65","first-page":"77","article-title":"Liver fibrosis associated with iron accumulation due to long-term heme-arginate treatment in acute intermittent porphyria: a case series","volume":"25","author":"Willandt","year":"2016","journal-title":"JIMD Rep"},{"key":"10.1053\/j.gastro.2019.04.050_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/joim.12750","article-title":"Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver","volume":"284","author":"Schmitt","year":"2018","journal-title":"J\u00a0Intern Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib67","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-018-0199-z","article-title":"Systemic messenger RNA as an etiological treatment for acute intermittent porphyria","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib68","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1038\/mtna.2015.36","article-title":"Preclinical development of a subcutaneous ALAS1 RNAi therapeutic for treatment of hepatic porphyrias using circulating RNA quantification","volume":"4","author":"Chan","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1053\/j.gastro.2019.04.050_bib69","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa1807838","article-title":"Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria","volume":"380","author":"Sardh","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib70","doi-asserted-by":"crossref","unstructured":"Balwani M, Gouya L, Rees D, et\u00a0al. ENVISION, a phase 3 study to evaluate efficacy and safety of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1, in acute hepatic porphyria patients. Abstract ILC 2019, GS14. EASL, Vienna, Austria,\u00a02019.","DOI":"10.1016\/S0618-8278(19)30142-2"},{"key":"10.1053\/j.gastro.2019.04.050_bib71","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(04)15646-8","article-title":"Liver transplantation as a cure for acute intermittent porphyria","volume":"363","author":"Soonawalla","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2019.04.050_bib72","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.27086","article-title":"Liver transplantation in the management of porphyria","volume":"60","author":"Singal","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.04.050_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/lt.22345","article-title":"Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis","volume":"18","author":"Dowman","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2019.04.050_bib74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-154-8-201104190-00015","article-title":"Liver transplantation from donors with acute intermittent porphyria","volume":"154","author":"Dowman","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib75","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A\u00a0porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.gastro.2019.04.050_bib76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00295407","article-title":"Familial and sporadic porphyria cutanea: two different diseases","volume":"44","author":"Verneuil","year":"1978","journal-title":"Hum Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib77","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archderm.139.3.309","article-title":"Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda","volume":"139","author":"St\u00f6lzel","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bcmd.2011.07.006","article-title":"Uroporphyria in the Cyp1a2-\/- mouse","volume":"47","author":"Phillips","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163322","article-title":"The D519G polymorphism of glyceronephosphate O-acyltransferase is a risk factor for familial porphyria cutanea tarda","volume":"11","author":"Farrell","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2019.04.050_bib80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bcmd.2016.11.009","article-title":"GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes","volume":"63","author":"Barton","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.taap.2007.03.007","article-title":"Hexachlorobenzene stimulates uroporphyria in low affinity AHR mice without increasing CYP1A2","volume":"221","author":"Gorman","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1053\/j.gastro.2019.04.050_bib82","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.1987.tb48775.x","article-title":"Porphyrinurias and occupational disease","volume":"514","author":"Doss","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.gastro.2019.04.050_bib83","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","article-title":"Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association","volume":"16","author":"Fargion","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.04.050_bib84","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/hep.1840210604","article-title":"Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany","volume":"21","author":"St\u00f6lzel","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.04.050_bib85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0676.1986.tb00282.x","article-title":"Hepatitis B virus infection in porphyria cutanea tarda","volume":"6","author":"Rocchi","year":"1986","journal-title":"Liver"},{"key":"10.1053\/j.gastro.2019.04.050_bib86","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","article-title":"Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis","volume":"39","author":"Gisbert","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib87","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2004.09.014","article-title":"The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population","volume":"52","author":"M\u00e9ndez","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib88","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archderm.139.3.379","article-title":"New reasons for an archaic treatment: phlebotomy in sporadic porphyria cutanea tarda","volume":"139","author":"Mascaro","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/asheducation.V2012.1.19.3795678","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"2012","author":"Balwani","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.gastro.2019.04.050_bib90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2133.1974.tb06367.x","article-title":"Treatment of porphyria cutanea tarda with chloroquine","volume":"90","author":"Kordac","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib91","first-page":"253","article-title":"Treatment of porphyria cutanea tarda by phlebotomy","volume":"14","author":"Ippen","year":"1977","journal-title":"Semin Hematol"},{"key":"10.1053\/j.gastro.2019.04.050_bib92","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archdermatol.2012.807","article-title":"Deferasirox for porphyria cutanea tarda: a pilot study","volume":"148","author":"Pandya","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib93","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2340\/0001555561346350","article-title":"A\u00a0comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda","volume":"61","author":"Malina","year":"1981","journal-title":"Acta Derm Venereol"},{"key":"10.1053\/j.gastro.2019.04.050_bib94","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","article-title":"Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda","volume":"10","author":"Singal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0009-2797(96)03732-5","article-title":"Effects of chloroquine in hematoporphyrin-treated animals","volume":"102","author":"Egger","year":"1996","journal-title":"Chem Biol Interact"},{"key":"10.1053\/j.gastro.2019.04.050_bib96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/cb300454t","article-title":"Insights into the role of heme in the mechanism of action of antimalarials","volume":"8","author":"Combrinck","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1053\/j.gastro.2019.04.050_bib97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000211340","article-title":"Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver","volume":"8","author":"Freesemann","year":"1995","journal-title":"Skin Pharmacol"},{"key":"10.1053\/j.gastro.2019.04.050_bib98","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2340\/00015555-0061","article-title":"Haemochromatosis gene mutations and response to chloroquine in sporadic porphyria cutanea tarda","volume":"86","author":"Toll","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1053\/j.gastro.2019.04.050_bib99","series-title":"Hydroxychloroquine and Chloroquine Retinopathy","first-page":"35","article-title":"Pharmacology of chloroquine and hydroxychloroquine","author":"Browning","year":"2014"},{"key":"10.1053\/j.gastro.2019.04.050_bib100","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1053\/j.gastro.2019.04.050_bib101","first-page":"223","article-title":"[Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine]","volume":"65","author":"Seubert","year":"1990","journal-title":"Z\u00a0Hautkr"},{"key":"10.1053\/j.gastro.2019.04.050_bib102","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1365-4632.2009.04205.x","article-title":"Does chloroquine therapy of porphyria cutanea tarda influence liver pathology?","volume":"48","author":"Wollina","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib103","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1111\/bjd.15502","article-title":"Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda","volume":"177","author":"Combalia","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib104","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/bjd.16741","article-title":"Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4-aminoquinoline antimalarial: a meta-analysis","volume":"179","author":"Salameh","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011676","article-title":"Erythroid heme biosynthesis and its disorders","volume":"3","author":"Dailey","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib106","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI108189","article-title":"Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts","volume":"56","author":"Bonkowsky","year":"1975","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2019.04.050_bib107","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.3748\/wjg.v16.i36.4526","article-title":"Liver disease and erythropoietic protoporphyria: a concise review","volume":"16","author":"Casanova-Gonz\u00e1lez","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.04.050_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2019.06.006","article-title":"Porphyrin-induced protein oxidation and aggregation as a mechanism of porphyria associated cell injury","author":"Maitra","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib109","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0009-9120(89)80081-5","article-title":"Hepatobiliary implications and complications in protoporphyria, a 20-year study","volume":"22","author":"Doss","year":"1989","journal-title":"Clin Biochem"},{"key":"10.1053\/j.gastro.2019.04.050_bib110","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jcp.27.9.698","article-title":"A\u00a0light and electron microscopic study of the liver in case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice","volume":"27","author":"Matilla","year":"1974","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1053\/j.gastro.2019.04.050_bib111","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, biochemical, and genetic characterization of North American patients with erythropoietic protoporphyria and X-linked protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib112","doi-asserted-by":"crossref","first-page":"E8045","DOI":"10.1073\/pnas.1700632114","article-title":"Mutation in human CLPX elevates levels of \u03b4-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria","volume":"114","author":"Yien","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.gastro.2019.04.050_bib113","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1373\/clinchem.2015.245456","article-title":"Pitfalls in erythrocyte protoporphyrin measurement for diagnosis and monitoring of protoporphyrias","volume":"61","author":"Gou","year":"2015","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2019.04.050_bib114","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/j.1440-1746.2010.06371.x","article-title":"Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis","volume":"25","author":"Malik","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib115","first-page":"84","article-title":"A\u00a0systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria","volume":"55","author":"Minder","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1053\/j.gastro.2019.04.050_bib116","first-page":"775","article-title":"A\u00a0review and update on melanocyte stimulating hormone therapy: afamelanotide","volume":"12","author":"Fabrikant","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib117","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40262-016-0501-5","article-title":"Pharmacokinetics and pharmacodynamics of afamelanotide and its clinical use in treating dermatologic disorders","volume":"56","author":"Minder","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1053\/j.gastro.2019.04.050_bib118","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1411481","article-title":"Afamelanotide for erythropoietic protoporphyria","volume":"373","author":"Langendonk","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib119","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJMc0805682","article-title":"An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria","volume":"360","author":"Harms","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0781.1998.tb00011.x","article-title":"Hepatic complications of erythropoietic protoporphyria","volume":"14","author":"Gross","year":"1998","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1053\/j.gastro.2019.04.050_bib121","first-page":"39","article-title":"Pathogenesis and therapy of liver disease in protoporphyria","volume":"52","author":"Bloomer","year":"1979","journal-title":"Yale J Biol Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib122","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12328-014-0501-7","article-title":"A\u00a0second attack of cholestasis associated with erythropoietic protoporphyria was successfully treated by plasma exchange and blood transfusion","volume":"7","author":"Honda","year":"2014","journal-title":"Clin J Gastroenterol"},{"key":"10.1053\/j.gastro.2019.04.050_bib123","series-title":"GeneReviews\u00ae","article-title":"Erythropoietic protoporphyria, autosomal recessive","author":"Balwani","year":"1993"},{"key":"10.1053\/j.gastro.2019.04.050_bib124","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/lt.21527","article-title":"Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria","volume":"14","author":"Wahlin","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2019.04.050_bib125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2006.10.004","article-title":"Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis","volume":"46","author":"Wahlin","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib126","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/ajt.14581","article-title":"Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: a case report","volume":"18","author":"Windon","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2019.04.050_bib127","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjh.13612","article-title":"X-linked protoporphyria: Iron supplementation improves protoporphyrin overload, liver damage and anaemia","volume":"173","author":"Landefeld","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1053\/j.gastro.2019.04.050_bib128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10545-017-0017-7","article-title":"Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity","volume":"40","author":"Barman-Aksoezen","year":"2017","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.29245\/2572-9411\/2017\/4.1110","article-title":"Iron in erythropoietic protoporphyrias: Dr. Jekyll or Mr. Hyde?","volume":"2","author":"Barman-Aksoezen","year":"2017","journal-title":"J\u00a0Rare Dis Res Treat"},{"key":"10.1053\/j.gastro.2019.04.050_bib130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajhg.2014.02.010","article-title":"Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria","volume":"94","author":"Oustric","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib131","first-page":"89","article-title":"Die H\u00e4matoporphyrie","volume":"105","author":"G\u00fcnther","year":"1911","journal-title":"Dtsch Arch Klin Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib132","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1432-1327.1998.2570149.x","article-title":"Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria","volume":"257","author":"Freesemann","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1053\/j.gastro.2019.04.050_bib133","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2006-06-022848","article-title":"Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria","volume":"109","author":"Phillips","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.gastro.2019.04.050_bib134","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ejh.12452","article-title":"Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis","volume":"94","author":"Di Pierro","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.gastro.2019.04.050_bib135","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2012.11160.x","article-title":"Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases","volume":"167","author":"Katugampola","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib136","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/petr.12571","article-title":"Successful hematopoietic stem cell transplantation in a child with congenital erythropoietic porphyria due to a mutation in GATA-1","volume":"19","author":"Karakurt","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1053\/j.gastro.2019.04.050_bib137","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2014-07-584664","article-title":"Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria","volume":"126","author":"Egan","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.gastro.2019.04.050_bib138","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2011-03-342873","article-title":"ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria","volume":"118","author":"To-Figueras","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.gastro.2019.04.050_bib139","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/hmg\/ddx067","article-title":"Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition","volume":"26","author":"Blouin","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2005.10.011","article-title":"delta-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations","volume":"87","author":"Akagi","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1053\/j.gastro.2019.04.050_bib141","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1186\/s12885-018-4754-2","article-title":"Early detection of colorectal adenocarcinoma: a clinical decision support tool based on plasma porphyrin accumulation and risk factors","volume":"18","author":"Lualdi","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1053\/j.gastro.2019.04.050_bib142","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1750-1172-7-93","article-title":"Establishing a network of specialist porphyria centres\u2014effects on diagnostic activities and services","volume":"7","author":"Toll\u00e5nes","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib143","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0004563216667965","article-title":"Best practice guidelines on first-line laboratory testing for porphyria","volume":"54","author":"Woolf","year":"2017","journal-title":"Ann Clin Biochem"},{"key":"10.1053\/j.gastro.2019.04.050_bib144","series-title":"Physician\u2019s Guide to\u00a0the Diagnosis, Treatment, and Follow-Up of Inherited\u00a0Metabolic Diseases","author":"Blau","year":"2014"},{"key":"10.1053\/j.gastro.2019.04.050_bib145","first-page":"5","article-title":"Aminolaevulinate dehydratase porphyria in infancy. A clinical and biochemical study","volume":"25","author":"Thunell","year":"1987","journal-title":"J\u00a0Clin Chem Clin Biochem"},{"key":"10.1053\/j.gastro.2019.04.050_bib146","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1034\/j.1399-0004.2002.620406.x","article-title":"Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene","volume":"62","author":"Floderus","year":"2002","journal-title":"Clin Genet"},{"key":"10.1053\/j.gastro.2019.04.050_bib147","series-title":"GeneReviews\u00ae","article-title":"Hepatoerythropoietic porphyria","author":"Liu","year":"1993"},{"key":"10.1053\/j.gastro.2019.04.050_bib148","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-1007138","article-title":"Variegate porphyria","volume":"18","author":"Kirsch","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib149","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2007-979983","article-title":"Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias","volume":"27","author":"Gross","year":"1995","journal-title":"Horm Metab Res"},{"key":"10.1053\/j.gastro.2019.04.050_bib150","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.1990.00390190115018","article-title":"A\u00a0gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria","volume":"150","author":"Anderson","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib151","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archderm.139.3.309","article-title":"Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda","volume":"139","author":"St\u00f6lzel","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.gastro.2019.04.050_bib152","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2119\/molmed.2010.00130","article-title":"CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda","volume":"17","author":"Wickliffe","year":"2011","journal-title":"Mol Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163322","article-title":"The D519G polymorphism of glyceronephosphate O-acyltransferase is a risk factor for familial porphyria cutanea tarda","volume":"11","author":"Farrell","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2019.04.050_bib154","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bcmd.2016.11.009","article-title":"GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes","volume":"63","author":"Barton","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.gastro.2019.04.050_bib155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.taap.2007.03.007","article-title":"Hexachlorobenzene stimulates uroporphyria in low affinity AHR mice without increasing CYP1A2","volume":"221","author":"Gorman","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1053\/j.gastro.2019.04.050_bib156","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.1987.tb48775.x","article-title":"Porphyrinurias and occupational disease","volume":"514","author":"Doss","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.gastro.2019.04.050_bib157","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","article-title":"Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association","volume":"16","author":"Fargion","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.04.050_bib158","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/phpp.12222","article-title":"Human immunodeficiency virus and risk of porphyria cutanea tarda: a possible association examined in a large hospital","volume":"32","author":"Aguilera","year":"2016","journal-title":"PhotodermatolPhotoimmunol Photomed"},{"key":"10.1053\/j.gastro.2019.04.050_bib159","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/hep.1840210604","article-title":"Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany","volume":"21","author":"St\u00f6lzel","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2019.04.050_bib160","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1528-1157.1991.tb04714.x","article-title":"Treatment of porphyric convulsions with magnesium sulfate","volume":"32","author":"Sadeh","year":"1991","journal-title":"Epilepsia"},{"key":"10.1053\/j.gastro.2019.04.050_bib161","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.seizure.2015.09.017","article-title":"Magnesium sulfate for non-eclamptic status epilepticus","volume":"32","author":"Zeiler","year":"2015","journal-title":"Seizure"},{"key":"10.1053\/j.gastro.2019.04.050_bib162","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJM198409063111006","article-title":"Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone","volume":"311","author":"Anderson","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib163","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1530\/eje.0.1410050","article-title":"Premenstrual attacks of acute intermittent porphyria: hormonal and metabolic aspects\u2014a case report","volume":"141","author":"De Block","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.gastro.2019.04.050_bib164","first-page":"57","article-title":"Audit of the use of regular haem arginate infusions in patients with acute porphyria to prevent recurrent symptoms","volume":"22","author":"Marsden","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1053\/j.gastro.2019.04.050_bib165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2119\/2004-00002.Johansson","article-title":"Biochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement","volume":"9","author":"Johansson","year":"2003","journal-title":"Mol Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib166","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00003088-200746040-00006","article-title":"Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion","volume":"46","author":"Sardh","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1053\/j.gastro.2019.04.050_bib167","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-018-0199-z","article-title":"Systemic messenger RNA as an etiological treatment for acute intermittent porphyria","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2019.04.050_bib168","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/bloodadvances.2017005660","article-title":"Effects of hemin and hemodialysis in a patient with acute intermittent porphyria and renal failure","volume":"1","author":"Attarian","year":"2017","journal-title":"Blood Adv"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519408834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519408834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:44:58Z","timestamp":1762163098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508519408834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":168,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0016508519408834"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2019.04.050","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Guide and Update on Porphyrias","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2019.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute","name":"copyright","label":"Copyright"}]}}